DR Lal Pathlabs
Dr Lal PathLabs Ltd is an Indian diagnostic and healthcare service provider operating a nationwide network of laboratories and patient service centers. The company offers pathology testing, blood tests, radiology imaging, genetic screening, and preventive health packages under the Dr Lal PathLabs brand. Main revenue drivers consist of patient diagnostic testing fees collected from walk-in patients, corporate health checkups, hospital outsourcing contracts, and home collection services. Dr Lal PathLabs serves individual patients, hospital networks, corporate employers, and medical practitioners across India. The company holds a market-leading position in India for retail pathology and diagnostic testing services. Headquartered in Gurugram, Haryana, India, it is listed on the National Stock Exchange of India and BSE.
2 of the funds FundTelligence covers report a position in DR Lal Pathlabs.
- Legal name
- DR LAL PATHLABS LTD
- Sector
- Health Care
- Country
- India
- Funds holding it
- 2
Funds holding DR Lal Pathlabs
- Nordea India — Nordea Funds · 1.27 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.01 % (full portfolio disclosed, October 2026)